Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients
Launched by POWER LIFE SCIENCES INC. · May 5, 2023
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the experiences of patients with hairy cell leukemia when it comes to participating in clinical studies. Specifically, it looks at why patients choose to join, leave, or return to these trials. By analyzing the experiences of different groups of people, the researchers hope to find common trends that could help improve future studies for this condition.
To participate in this trial, you need to be at least 18 years old and able to understand the study details and give your consent. You should also be willing to attend scheduled visits and follow the study requirements. However, if you are pregnant, breastfeeding, or have certain medical or mental health issues that might prevent you from understanding the trial, you may not be eligible. If you decide to join, you can expect to share your experiences and insights, which could play a vital role in enhancing research for hairy cell leukemia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged ≥ 18 years old
- • Ability to understand and the willingness to sign a written informed consent document.
- • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
- Exclusion Criteria:
- • Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- • Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
- • Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported